Highlights

  • AFT Pharmaceuticals Ltd (ASX: AFP) traded at $3.95 as at 3:00pm AEST on August 7, 2026.
  • The stock recorded an increase of approximately 0.25 percent for the session based on the data reviewed.
  • The day high and day low were both recorded at $3.95.
  • Market capitalisation stood at approximately $414.25 million.
  • Trading volume was recorded at 19 shares during the session.

AFT Pharmaceuticals Ltd (ASX: AFP) shares were trading at $3.95 as at 3:00pm AEST on August 7, 2026, with limited intraday price movement during the reviewed session. The stock recorded an increase of approximately 0.25 percent, while the broader S&P/ASX 200 Health Care Index traded lower during the same period.

AFT Pharmaceuticals Share Price Movement on August 7, 2026

AFT Pharmaceuticals shares recorded an increase of approximately 0.25 percent for the session based on the reviewed market data. The stock’s day high and day low were both recorded at $3.95, indicating no recorded difference between the highest and lowest traded price during the session.

Limited daily movement can occur when trading activity remains low or when there are fewer transactions recorded during the period reviewed. Share price movements are generally considered alongside trading volume and broader market conditions.

Trading Volume and Market Capitalisation

Trading volume for AFT Pharmaceuticals was recorded at 19 shares during the session. Based on the reported share price, the company’s market capitalisation stood at approximately $414.25 million.

The limited trading volume reflected the level of market activity captured during the reviewed period, while the company’s market capitalisation placed it among the pharmaceutical companies listed within the ASX health care sector.

One-Year Share Price Performance

Over the trailing one-year period, AFT Pharmaceuticals recorded an increase of approximately 57.37 percent based on the data reviewed.

Share price movements over a twelve-month period can reflect a combination of company-specific developments, broader sector trends and overall market conditions. Individual company performance may differ from movements across the wider health care sector.

ASX Health Care Sector Performance

The broader S&P/ASX 200 Health Care Index (XHJ) was trading at 28,010.8 points, down 224.7 points or 0.80 percent, as at 3:20pm AEST on August 7, 2026, with the market session still open.

The index traded within an intraday range of 27,808.8 to 28,235.5 points against a previous close of 28,235.5. Over the past 52 weeks, the index ranged between 21,947.2 and 45,579.6 points, with a one-year return of negative 37.37 percent.

Individual health care companies can record different share price movements from the broader index due to company-specific factors, trading activity and market participation.

About AFT Pharmaceuticals Ltd

AFT Pharmaceuticals Ltd is a pharmaceutical company listed on the ASX under the ticker code AFP and classified within the health care sector.

The company’s share price activity can be influenced by company-specific developments, broader pharmaceutical sector conditions and overall market sentiment.

Understanding the Trading Data

The share price, trading volume and market capitalisation figures provide an overview of AFT Pharmaceuticals’ market activity during the reviewed session.

Trading volume represents the number of shares exchanged during the period, while market capitalisation reflects the market value based on the reported share price and shares on issue. A single trading session represents activity during a specific period and may not reflect longer-term share price trends.

Conclusion

As at 3:00pm AEST on August 7, 2026, AFT Pharmaceuticals Ltd (ASX: AFP) shares were trading at $3.95, with the day high and low both recorded at $3.95, trading volume of 19 shares and market capitalisation of approximately $414.25 million.

The stock recorded an increase of approximately 0.25 percent during the session, while the broader S&P/ASX 200 Health Care Index traded lower. The reviewed data provides an overview of AFT Pharmaceuticals’ share price activity and position within the ASX health care sector.